Studies on the metabolic fate of valproic acid in the rat using stable isotope techniques

References

• Acheampong A., Abbott F. S. Synthesis and stereochemical determination of diunsaturated valporic acid analogs including its major diunsaturated metabolite. Journal of Lipid Research 1985; 26: 1002–1008
   PubMedGoogle Scholar
• Acheampong A., Abbott F., Burton R. Identification of valproic acid metabolites in human serum and urine using hexadeuterated valproic acid and gas chromatographic mass spectrometric analysis. Biomedical Mass Spectrometry 1983; 10: 586–595
   PubMedGoogle Scholar
• Adams R., Kamm R. M. Synthesis of ethyl n-butylmalonate. Orgnic Syntheses. Collective Volume I 2nd edition, A. H. Blatt. Wiley, New York 1941; 250–251
   Google Scholar
• Bjorge S. M., Baillie T. A. Inhibition of medium-chain fatty acid β-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid. Biochemical and Biophysical Research Communications 1985; 132: 245–252
   PubMed Web of Science ®Google Scholar
• Granneman G. R., Wang S. I., Machinist J. M., Kesterson J. W. Aspects of the metabolism of valproic acid. Xenobiotica 1984; 14: 375–387
   PubMed Web of Science ®Google Scholar
• Groves J. T., McClusky G. A., White R. E., Coon M. J. Aliphatic hydroxylation by highly purified liver microsomal cytochrome P-450. Evidence for a carbon radical intermediate. Biochemical Biophysical Research Communications 1978; 81: 154–160
   PubMed Web of Science ®Google Scholar
• Guglfr R., Von Unruh G. E. Clinical pharmacokinetics of valproic acid. Clinical Pharmacokinetics 1980; 5: 67–83
   PubMedGoogle Scholar
• Heinemeyer G., Nau H., Hildebrandt A. G., Roots I. Oxidation and glucuronidation of valproic acid in male rats—influence of phenobarbital, 3-methylcholanthrene, β-naphthoflavone and clofibrate. Biochemical Pharmacology 1985; 34: 133–139
   PubMed Web of Science ®Google Scholar
• Hjelmeland L. M., Aronow L., Trudell J. R. Intramolecular determination of primary kinetic isotope effects in hydroxylations catalyzed by cytochrome P-450. Biochemical Biophysical Research Communications 1977; 76: 541–549
   Web of Science ®Google Scholar
• Jezequel A. M., Bonazzi P., Novelli G., Venturini C., Orlandi F. Early structural and functional changes in liver of rats treated with a single dose of valproic acid. Hepatology 1984; 4: 1159–1166
   PubMed Web of Science ®Google Scholar
• Kesterson J. W., Granneman G. R., Machinist J. M. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology 1984; 4: 1143–1152
   PubMed Web of Science ®Google Scholar
• Kochen W., Scheffner H. On unsaturated metabolites of the valproic acid (VPA) in serum of epileptic children. Antiepileptic Therapy: Advances in Drug Monitoring, S. I. Johannessen. Raven Press, New York 1980; 111–117
   Google Scholar
• Kochen W., Sprunck H. P., Tauscher B., Klemens M. Five doubly unsaturated metabolites of valproic acid in urine and plasma of patients on valproic acid therapy. Journal of Clinical Chemistry and Clinical Biochemistry 1984; 22: 309–317
   PubMedGoogle Scholar
• Lewis J. H., Zimmerman H. J., Garrett C. T., Rosenberg E. Valproate-induced hepatic steatogenesis in rats. Hepatology 1982; 2: 870–873
   PubMed Web of Science ®Google Scholar
• Matsumoto I., Kuhara T., Yoshino M. Metabolism of branched medium chain length fatty acid. II. β-Oxidation of sodium dipropylacetate in rats. Biomedical Mass Spectrometry 1976; 3: 235–240
   PubMedGoogle Scholar
• Mortensen P. B. Inhibition of fatty acid oxidation by valproate. Lancet 1980; ii: 856–857
   Google Scholar
• Mortensen P. B., Gregersen N., Kolvraa S., Christensen E. The occurrence of C6-C10-dicarboxylic acids in urine from patients and rats treated with dipropylacetate. Biochemical Medicine 1980; 24: 153–161
   PubMedGoogle Scholar
• Prickett K. S., Baillie T. A. Metabolism of valproic acid by hepatic microsomal cytochrome P-450. Biochemical and Biophysical Research Communications 1984; 122: 1166–1173
   PubMed Web of Science ®Google Scholar
• Prickett K. S., Baillie T. A. Metabolism of unsaturated derivatives of valproic acid in rat liver microsomes and destruction of cytochrome P-450. Drug Metabolism and Disposition 1986; 14: 221–228
   PubMed Web of Science ®Google Scholar
• Reinsch J., Katz A., Wean J., Aprahamian G., McFarland J. T. The deuterium isotope effect upon the reaction of fatty acyl-CoA dehydrogenase and butyryl-CoA. Journal of Biological Chemistry 1980; 255: 9093–9097
   PubMedGoogle Scholar
• Rettenmeier A. W., Gordon W. P., Prickett K. S., Levy R. H., Lockard J. S., Thummel K. E., Baillie T. A. Metabolic fate of valproic acid in rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid. Drug Metabolism and Disposition 1986; 14: 443–453
   PubMed Web of Science ®Google Scholar
• Rettenmeier A. W., Prickett K. S., Gordon W. P., Bjorge S. M., Chang S.-L., Levy R. H., Baillie T. A. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates. Drug Metabolism and Disposition 1985; 13: 81–96
   PubMed Web of Science ®Google Scholar
• Schobben F., Van Der Kleijn E. Valproate. Biotransformation. Antiepileptic Drugs, D. M. Woodbury. Raven Press, New York 1982; 567–578
   Google Scholar
• Thurston J. H., Carroll J. E., Norris B. J., Hauhart R. E., Schiro J. A. Acute in vivo and in vitro inhibition of palmitic acid and pyruvate oxidation by valproate and valproyl-coenzyme A in livers of infant mice. Annals of Neurology 1983; 14: 384–385
   Google Scholar
• Thurston J. H., Carroll J. E., Hauhart R. E., Schiro J. A. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance. Life Sciences 1985; 36: 1643–1651
   PubMed Web of Science ®Google Scholar
• Zimmerman H. J., Ishak K. G. Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 1982; 2: 591–597
   PubMed Web of Science ®Google Scholar